Product Images Clindamycin Phosphate

This is a description of Clindamycin Injection USP in 5% Dextrose. The injection comes in a 600mg per 50mL (12mg/mL) single-dose container that should be discarded if unused. It is not for rapid injection or intraveneous push, but can be used for intravenous purposes. The injection should not be used with other medication or in series connections. It should be checked for leaks and solution clarity. The injection should be stored between 20° to 25°C (68° to 77°F) and should be avoided at temperatures above 30°C. The dosage depends on the prescription. PremierProRx® PL 2501 Plasti is the registered trademark of Premier Healthcare Allance, L. Baxter International Inc is a registered trademark of Jaxy. The injection is manufactured by Baxter Healthcare Corporation, Deerfel, IL 60015 USA, and was made in the USA on 07-34-00-075.*

The text provides information about the GALAXY Container and the drug Clindamycin Injection USP in 5% Dextrose, which comes in a 50 mL single dose container. The container features the trademark of PremierProRx and was manufactured in the USA by Baxter Healthcare Corporation. PL 2501 Plastic is also mentioned. Storage temperature recommendations are included.*

This is a medication with intravenous use that contains Gindamycin phosphate, USP equivalent to 600 mg cindamyci, 25 g dexrose ydous, USP, 2mg edetate disodium diydrate, USP, and Water for Injection, USP. The pH may have been adjusted with sodium hygrovide and/or hydrochloric acid. It is caution not to add supplementary medication, not to use in series connections and to check for minute leaks and solution clarity. Dosage should be checked on prescribing information.*

This is a description of Clindamycin Injection USP in 5% Dextrose, a medication used for intravenous use. Each 50 mL of the solution contains 900 mg of Clindamycin phosphate, USP, 25 g of dextrose hydrous, USP, 2 mo edetate disodium iydrate, USP, and Water for Injection, USP. The pH may have been adjusted with sodium hydroxide and/or hydrochloric acid. The dosage information is provided in the product's prescribing information. The medication should not be used in series connections, and leaks should be checked for. It must be stored at 20° to 25°C (68° to 77°F) and should be kept away from temperatures above 30°C. The medication is manufactured and distributed by Baxter Healthcare Corporation.*

This is a product description for a medical product named "GALAXY Container PL 2501 Plastic" containing "Clindamycin Injection USP" with "900 mg per 50 mL (18 mg / mL)". The container has a single dose and contains 1250 mL. The product is manufactured in the USA by Baxter Healthcare Corporation. The product should be stored at 20-25°C (5-77°F) at USP Controlled Room Temperature and should be protected from temperatures above 31°C.*

This is a description of a medication that can only be obtained through prescription. It is an injection that is given via intravenous push, and comes in a 50 ml container. The medication contains Gindamycin phosphate, which is equivalent to 500 mg of cindamycin, 25 g of dexrose ydious, USP, 2 mg of sdtae disodium diydrate, USP, and Water for Injection, USP. The pH may have been adjusted using sodium hygroxide and/or hydrochloric acid. Dosage information is available in the prescribing information, and it is important to not add supplementary medication or use it in series connections. Minute leaks and solution clarity should be checked before use.*

This is a description of Clindamycin Injection USP in 5% Dextrose, which contains 900mg per 50mL. It is assigned with Code 2G3459 and NDC 0338-4114-24. It should be stored in a controlled room temperature of 20°C to 25°C (68°F to 77°F) to avoid temperatures above 30°C. The product is labeled with the brand name PREMIERProRx®. However, towards the end of the text, there are seemingly random characters and numbers that do not convey any meaningful information.*